Immunoglobulin aggregation leading to Russell body formation is prevented by the antibody light chain

Blood

Volumn 115, Issue 2, 2010, Pages 282-288

  Corcos, Daniel ^a   Osborn, Michael J ^a   Matheson, Louise S ^a   Santos, Fatima ^a   Zou, Xiangang ^a   Smith, Jennifer A ^a   Morgan, Geoff ^a   Hutchings, Amanda ^a   Hamon, Maureen ^a   Oxley, David ^a   Brüggemann, Marianne ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; SYNDECAN 1; SDC1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL INCLUSION; CONSTANT REGION ALPHA; CONSTANT REGION GAMMA; CONSTANT REGION H1; CONSTANT REGION H2; CONSTANT REGION MU; CONTROLLED STUDY; HEAVY CHAIN DISEASE; HYBRIDOMA; IMMUNOGLOBULIN AGGREGATE; IMMUNOGLOBULIN CONSTANT REGION; KNOCKOUT MOUSE; MOTT CELL; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; RUSSELL BODY; ANIMAL; GENE TARGETING; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALS; GENE KNOCK-IN TECHNIQUES; IMMUNOGLOBULIN CONSTANT REGIONS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; INCLUSION BODIES; MICE; MICE, KNOCKOUT; PLASMA CELLS; SYNDECAN-1;

EID: 75649140280     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-07-234864     Document Type: Article

References (48)

1. Haas IG, Wabl M. Immunoglobulin heavy chain binding protein. Nature. 1983;306(5941):387-389.
2. Gething MJ. Role and regulation of the ER chaperone BiP. Semin Cell Dev Biol. 1999;10(5):465-472.
3. Kleizen B, Braakman I. Protein folding and quality control in the endoplasmic reticulum. Curr Opin Cell Biol. 2004;16(4):343-349.
4. Decourt C, Galea HR, Sirac C, Cogne M. Immunologic basis for the rare occurrence of true nonsecretory plasma cell dyscrasias. J Leukoc Biol. 2004;76(3):528-536.
5. Jiang Y, Hirose S, Hamano Y, et al. Mapping of a gene for the increased susceptibility of B1 cells to Mott cell formation in murine autoimmune disease. J Immunol. 1997;158(2):992-997.
6. Kopito RR, Sitia R. Aggresomes and Russell bodies. Symptoms of cellular indigestion? EMBO Rep. 2000;1(3):225-231.
7. Buxbaum JN, Alexander A. Heavy-chain-diseases. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, eds. Williams Hematology. 6th ed. New York: McGraw-Hill; 2001:1327-1336.
8. Köhler G, Potash MJ, Lehrach H, Shulman MJ. Deletions in immunoglobulin mu chains. Embo J. 1982;1(5):555-563.
9. Pollok BA, Anker R, Eldridge P, Hendershot L, Levitt D. Molecular basis of the cell-surface expression of immunoglobulin mu chain without light chain in human B lymphocytes. Proc Natl Acad Sci U S A. 1987;84(24):9199-9203.
10. Aucouturier P, Khamlichi AA, Touchard G, et al. Brief report: heavy-chain deposition disease. N Engl J Med. 1993;329(19):1389-1393.
11. Liapis H, Papadakis I, Nakopoulou L. Nodular glomerulosclerosis secondary to mu heavy chain deposits. Hum Pathol. 2000;31(1):122-125.
12. Spanopoulou E, Roman CA, Corcoran LM, et al. Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev. 1994;8(9):1030-1042.
13. Young F, Ardman B, Shinkai Y, et al. Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation. Genes Dev. 1994; 8(9):1043-1057.
14. Schuh W, Meister S, Roth E, Jack HM. Cutting edge: signaling and cell surface expression of a mu H chain in the absence of lambda 5: a paradigm revisited. J Immunol. 2003;171(7):3343-3347.
15. Su YW, Flemming A, Wossning T, Hobeika E, Reth M, Jumaa H. Identification of a pre-BCR lacking surrogate light chain. J Exp Med. 2003; 198(11):1699-1706.
16. Galler GR, Mundt C, Parker M, Pelanda R, Martensson IL, Winkler TH. Surface mu heavy chain signals down-regulation of the V(D)J-recombinase machinery in the absence of surrogate light chain components. J Exp Med. 2004; 199(11):1523-1532.
17. Geraldes P, Rebrovich M, Herrmann K, et al. Ig heavy chain promotes mature B cell survival in the absence of light chain. J Immunol. 2007; 179(3):1659-1668.
18. Ohnishi K, Melchers F. The nonimmunoglobulin portion of lambda5 mediates cell-autonomous pre-B cell receptor signaling. Nat Immunol. 2003; 4(9):849-856.
19. Bankovich AJ, Raunser S, Juo ZS, Walz T, Davis MM, Garcia KC. Structural insight into pre-B cell receptor function. Science. 2007;316(5822):291-294.
20. Meixlsperger S, Kohler F, Wossning T, Reppel M, Muschen M, Jumaa H. Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor. Immunity. 2007;26(3):323-333.
21. Zou X, Osborn MJ, Bolland DJ, et al. Heavy chain-only antibodies are spontaneously produced in light chain-deficient mice. J Exp Med. 2007;204(13):3271-3283.
22. Matheson LS, Osborn MJ, Smith JA, et al. Light chain-deficient mice produce novel multimeric heavy-chain-only IgA by faulty class switching. Int Immunol. 2009;21(8):957-966.
23. Zou X, Piper TA, Smith JA, Allen ND, Xian J, Brüggemann M. Block in development at the pre-B-II to immature B cell stage in mice without Ig kappa and Ig lambda light chain. J Immunol. 2003;170(3):1354-1361.
24. Zou X, Ayling C, Xian J, Piper TA, Barker PJ, Brüggemann M. Truncation of the mu heavy chain alters BCR signalling and allows recruitment of CD5+ B cells. Int Immunol. 2001;13(12): 1489-1499.
25. Zou X, Smith JA, Corcos D, Matheson LS, Osborn MJ, Brüggemann M. Removal of the BiP-retention domain in Cmicro permits surface deposition and developmental progression without L-chain. Mol Immunol. 2008;45(13):3573-3579.
26. Ren L, Zou X, Smith JA, Brüggemann M. Silencing of the immunoglobulin heavy chain locus by removal of all eight constant-region genes in a 200-kb region. Genomics. 2004;84(4):686-695.
27. Galfrè G, Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol. 1981;73(Pt B):3-46.
28. Zou X, Smith JA, Nguyen VK, et al. Expression of a dromedary heavy chain-only antibody and B cell development in the mouse. J Immunol. 2005;175(6):3769-3779.
29. Pilström L. The mysterious immunoglobulin light chain. Dev Comp Immunol. 2002;26(2):207-215.
30. Criscitiello MF, Flajnik MF. Four primordial immunoglobulin light chain isotypes, including lambda and kappa, identified in the most primitive living jawed vertebrates. Eur J Immunol. 2007;37(10): 2683-2694.
31. Stanfield RL, Zemla A, Wilson IA, Rupp B. Antibody elbow angles are influenced by their light chain class. J Mol Biol. 2006;357(5):1566-1574.
32. Lam KP, Kuhn R, Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell. 1997;90(6):1073-1083.
33. Kraus M, Alimzhanov MB, Rajewsky N, Rajewsky K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell. 2004;117(6):787-800.
34. Köhler G. Immunoglobulin chain loss in hybridoma lines. Proc Natl Acad Sci U S A. 1980;77(4): 2197-2199.
35. Roux KH, Greenberg AS, Greene L, et al. Structural analysis of the nurse shark (new) antigen receptor (NAR): molecular convergence of NAR and unusual mammalian immunoglobulins. Proc Natl Acad Sci U S A. 1998;95(20):11804-11809
36. Rast JP, Amemiya CT, Litman RT, Strong SJ, Litman GW. Distinct patterns of IgH structure and organization in a divergent lineage of chrondrichthyan fishes. Immunogenetics. 1998;47(3):234-245.
37. Hamers-Casterman C, Atarhouch T, Muyldermans S, et al. Naturally occurring antibodies devoid of light chains. Nature. 1993;363(6428):446-448.
38. Baczynsky WO, Sugii S, Murialdo H, et al. Nucleotide sequences of immunoglobulin mu heavy chain deletion mutants. Nucleic Acids Res. 1983; 11(21):7471-7485.
39. Jack HM, Wabl M. High rates of deletions in the constant region segment of the immunoglobulin mu gene. Proc Natl Acad Sci U S A. 1987;84(14): 4934-4938.
40. Xu Z, Fulop Z, Zhong Y, Evinger AJ 3rd, Zan H, Casali P. DNA lesions and repair in immunoglobulin class switch recombination and somatic hypermutation. Ann N Y Acad Sci. 2005;1050:146-162.
41. Gass JN, Gunn KE, Sriburi R, Brewer JW. Stressed-out B cells? Plasma-cell differentiation and the unfolded protein response. Trends Immunol. 2004;25(1):17-24.
42. Valetti C, Grossi CE, Milstein C, Sitia R. Russell bodies: a general response of secretory cells to synthesis of a mutant immunoglobulin which can neither exit from, nor be degraded in, the endoplasmic reticulum. J Cell Biol. 1991;115(4):983-994.
43. Mattioli L, Anelli T, Fagioli C, Tacchetti C, Sitia R, Valetti C. ER storage diseases: a role for ERGIC-53 in controlling the formation and shape of Russell bodies. J Cell Sci. 2006;119(Pt 12):2532-2541.
44. Roholt O, Onoue K, Pressman D. Specific combination of H and L chains of rabbit gamma-globulins. Proc Natl Acad Sci U S A. 1964;51(2):173-178.
45. Weidenhaupt M, Khalifa MB, Hugo N, Choulier L, Altschuh D, Vernet T. Functional mapping of conserved, surface-exposed charges of antibody variable domains. J Mol Recognit. 2002;15(2):94-103.
46. Tolar P, Hanna J, Krueger PD, Pierce SK. The constant region of the membrane immunoglobulin mediates B cell-receptor clustering and signaling in response to membrane antigens. Immunity. 2009;30(1):44-55.
47. Corcos D, Dunda O, Butor C, et al. Pre-B-cell development in the absence of lambda 5 in transgenic mice expressing a heavy-chain disease protein. Curr Biol. 1995;5(10):1140-1148.
48. Carrell RW. Cell toxicity and conformational disease. Trends Cell Biol. 2005;15(11):574-580.